Packaged Foods and Meats

Scitop Bio

Scitop Bio released FY2025 Q4 earnings on April 21 After-Market (BJT), actual revenue CNY 98.53 M, actual EPS CNY 0.0699

Scitop Bio released FY2026 Q1 earnings on April 21 After-Market (BJT), actual revenue CNY 85 M, actual EPS CNY 0.06

Scitop Bio released FY2025 earnings on April 21 After-Market (BJT), actual revenue CNY 365.92 M (forecast CNY 504 M), actual EPS CNY 0.36 (forecast CNY 0.63)

Scitop Bio FY2026 Q1 Earnings Release Scheduled for April 22 After-Market BJT

Scitop Bio to Release FY2025 Annual Earnings on April 22 After-Market (BJT), Forecast Revenue CNY 504 M, EPS CNY 0.63

Scitop Bio released FY2025 Q3 earnings on October 21 During-Market BJT, actual revenue CNY 104.04 M, actual EPS CNY 0.128

Scitop Bio released FY2025 9 Months Earnings on October 21 During-Market (BJT), actual revenue CNY 267.39 M, actual EPS CNY 0.288

Scitop Bio to Release FY2025 Q3 Earnings on October 22 During-Market (BJT)

Scitop Bio released FY2025 Q2 earnings on August 19 After-Market (BJT), actual revenue CNY 85.73 M, actual EPS CNY 0.08

Scitop Bio released FY2025 Semi-Annual Earnings on August 19 After-Market BJT, actual revenue CNY 163.35 M, actual EPS CNY 0.16

Scitop Bio to Release FY2025 Semi-Annual Earnings on August 20, 2025 (BJT)

Keda Bio Responds to Shenzhen JunTuo's Innovative Drug Project Progress

Eastwu Securities Report Recommends Buying KETO BioTech

Investors Inquiring About Kebotech's Probiotics Products Details

Eastwu Securities Issues Buy Rating on Kehuobio

Ketuo Bio CSO Responds to Investors on Product and Marketing Strategies

Ketuo Bio Added Soil Remediation Concept

Ketuo Bio Received 'Buy' Rating from Eastwu Securities

Eastwu Securities Publishes Research Report on Ketao Biotech

Keto Bio Creates a 60-Day High and Receives a Buy Rating from Dongwu Securities

516670

159865

159867

516760

Live cattle futures saw a slight increase of 12 cents in June contracts, while other contracts fell by 30 to 40 cents. Cash trade ranged from $260-265 in the South and $408-415 in the North. Feeder cattle futures dropped by $2 to $2.35. China renewed export licenses for over 400 US beef plants and committed to purchasing $17 billion annually of U.S. agricultural products from 2026 to 2028. Wholesale boxed beef prices rose, with USDA estimating cattle slaughter at 53,500 head last week.

nasdaq

China Merchants CSI Animal Husbandry ETF

Guotai CSI Animal Husbandry ETF

Penghua CSI Animal Husbandry ETF

Ping An CSI Animal Husbandry ETF

Nasdaq

Cattle Slipping Lower on Monday

300858

Scitop Bio released its Q3 2025 report, with revenue for the first three quarters reaching 267 million yuan, a year-on-year increase of 22.25%; net profit attributable to the parent company was 76.232 million yuan, a year-on-year increase of 7.08%; net profit excluding non-recurring gains and losses was 67.078 million yuan, a year-on-year increase of 9.79%; basic earnings per share were 0.29 yuan

Zhitong

Scitop Bio released its performance for the first three quarters, with a net profit attributable to the parent company of 76.232 million yuan, an increase of 7.08%

According to the announcement from Scitop Bio, a specific shareholder, Zhang Liebing, who holds 4.1764% of the shares, plans to reduce his holdings within three months after the disclosure of the reduction announcement (from October 16, 2025, to January 15, 2026) through centralized bidding and block trading, with the number of shares to be reduced not exceeding 5 million shares, which is no more than 1.8976% of the total shares of the company

Scitop Bio specific shareholder Zhang Liebing plans to reduce his holdings by no more than 1.8976%

According to the Zhitong Finance APP, Scitop Bio announced that the company recently received a "Notice of Share Reduction Plan" from shareholders holding more than 5% of the shares, including Ningbo Shunyi, specific shareholder Ningbo Kehuidai, and director and deputy general manager Qiao Xiangqian. The above shareholders plan to collectively reduce their holdings by no more than 5% of the company's shares

Scitop Bio shareholders plan to reduce their holdings by no more than 5%

002574

603900

300703

603697

The new consumption concept is gaining momentum, with health drinks, snacks, jewelry, and IP economy all performing well. More than a dozen constituent stocks, including Cre8 Direct, Scitop Bio, YouYou Foods, Jiaoda Onlly, Ming Jewelry, and Leysen, have hit the daily limit up

Ming Jewelry

Leysen

Cre8 Direct

YouYou Foods

JIAODA ONLLY

The new consumption concept continues to rise, with more than a dozen constituent stocks hitting the daily limit

300106

605388

300997

300898

36Kr learned that as of the time of publication, consumer stocks such as food and dairy continue to be active, with Juneyao Grand Healthy Drinks achieving a 2-day limit up, Scitop Bio rising over 10%, and companies like QuanYangQuan, HUANLEJIA, Pinwo Foods, PANDAIRY, and WESTERN ANIMAL also following suit

36Kr

WESTERN ANIMAL

Juneyao Grand Healthy Drinks

HUANLEJIA

PANDAIRY

JLQYQ

PINLIVE

Consumer stocks such as food and dairy continue to be active, Juneyao Grand Healthy Drinks has achieved a 2-day trading limit

Scitop Bio released its Q1 2025 performance report, with operating revenue of 77.6129 million yuan, a year-on-year increase of 31.49%; net profit attributable to the parent company of 20.3296 million yuan, a year-on-year increase of 9.79%; net profit after deducting non-recurring gains and losses of 16.6648 million yuan, a year-on-year increase of 9.55%; basic earnings per share of 0.08 yuan

Scitop Bio released its first-quarter performance, with a net profit attributable to the parent company of 20.3296 million yuan, an increase of 9.79%

Scitop Bio released its 2024 annual report, with operating revenue of 303 million yuan, a year-on-year increase of 1.19%; net profit attributable to the parent company was 94.3561 million yuan, a year-on-year increase of 0.94%; net profit excluding non-recurring gains and losses was 82.2823 million yuan, a year-on-year increase of 2.26%. The basic earnings per share were 0.36 yuan, and it plans to distribute a cash dividend of 1.50 yuan (including tax) for every 10 shares to all shareholders

Scitop Bio released its 2024 annual performance, with a net profit attributable to the parent company of 94.3561 million yuan, an increase of 0.94%

According to the Zhitong Finance APP, Scitop Bio announced that the implementation period for the share reduction plans of its shareholders Kerongda and specific shareholder Kehuidai has expired, with a total reduction of 6.0698 million shares

Scitop Bio was jointly reduced by shareholders Kairongda and Kehuidai by a total of 6.0698 million shares

According to the announcement from Scitop Bio, a specific shareholder, Zhang Liebing, who holds 4.9453% of the company's shares, plans to reduce his holdings by no more than 4 million shares, which is no more than 1.5181% of the total shares of the company, within three months after the disclosure of this reduction announcement through centralized bidding or block trading

Scitop Bio specific shareholder Zhang Liebing plans to reduce his holdings by no more than 1.5181%

Scitop Bio(300858.SZ)